Nucleai
Emanuel Timor serves as a General Partner at Vertex Ventures Israel since 1998 and holds multiple board member positions at various companies, including Aporia, Cymbio, Upswift.io, Adaptive Shield, Cymulate, Codefresh, ZenCity, Nucleai, and Atidot, demonstrating a significant commitment to the startup ecosystem. Emanuel Timor's academic background includes a Bachelor of Laws (LLB) and a Bachelor of Arts in Economics from Tel Aviv University, which were completed between 1993 and 1997.
This person is not in the org chart
This person is not in any offices
Nucleai
7 followers
Nucleai is a spatial biology company that has developed an AI-powered platform to enhance drug development and improve patient outcomes. Nucleai’s platform leverages unique tissue datasets to produce insights into cancer biology, increasing clinical trial efficacy and improving patient care. Nucleai works with leading pharmaceutical companies,licensing its research platform for internal use, and collaborating in biomarkers discovery projects.